Tenet's Blockbuster Quarter Sends Stock Flying, 2026 Outlook Gets Major Upgrade

Tenet Healthcare Corp. (NYSE: THC ) stock surged Friday after the company reported second-quarter results that beat Wall Street estimates and raised its fiscal 2026 earnings and revenue guidance.

The hospital operator reported adjusted earnings of $6.12 per share, topping the analyst consensus estimate of $4.23.

Revenue rose 6.8% year over year to $5.63 billion, exceeding the consensus estimate of $5.43 billion.

Same-Store Growth Boosts Results Chairman and CEO Saum Sutaria attributed the strong quarter to solid same-store revenue growth and disciplined expense management. “Strong same-store revenue growth and effective expense management drove our fundamental outperformance in the second quarter of 2026 compared to our original assumptions,” Sutaria said.

During the earnings call, Sutaria acknowledged ongoing uncertainty around payer mix and insurance enrollment in the Exchanges and Medicaid.

However, he said the company’s growth initiatives and cost controls helped offset those headwinds.

Read Also: HCA Healthcare Surpasses Q2 Estimates With Strong Admissions Growth Higher Acuity Lifts Hospital Performance The ambulatory care segment posted revenue of $1.39 billion, up 9.3% from a year earlier.

Growth was driven by higher same-facility net patient service revenue, facility acquisitions and expanded service lines.

Same-facility ambulatory net patient service revenue increased 5.0%.

While cases declined 1.2%, net revenue per case rose 6.3% because of higher-acuity procedures and a more favorable service mix.

Hospital segment revenue increased 6.0% to $4.24 billion, supported by higher adjusted admissions and increased patient acuity.

Lower Exchange admissions created an unfavorable payer mix that partially offset the gains.

Same-hospital net patient service revenue per adjusted admission rose 3.3% year over year.

The increase reflected stronger commercial employer revenue and higher Medicaid supplemental payments, partly offset by weaker Exchange admissions.

Tenet Raises 2026 Outlook Tenet increased its fiscal 2026 adjusted earnings guidance to a range of $20.30 to $21.69 per share from its prior outlook of $16.38 to $18.68 per share.

The new forecast is well above the analyst consensus estimate of $17.88 per share.

The company also raised its full-year revenue guidance to $21.9 billion-$22.5 billion from $21.5 billion-$22.3 billion.

Analysts had expected revenue of about $22.0 billion.

Tenet also increased its expectations for acquisitions.

Sutaria said the company now expects to spend more than $300 million on mergers and acquisitions in 2026, citing completed ambulatory surgery acquisitions and a strong deal pipeline.

THC Price Action: Tenet Healthcare shares were up 16.52% at $231.90 at the time of publication on Friday, according to Pro data.

Image via Shutterstock Read Also: Jeff Bezos Said ‘I Predict One Day Amazon Will Fail.

Amazon Will Go Bankrupt’ — But the Key to Prolonging That Demise Is to ‘Obsess Over Customers’